Cannabis Insurance Federal Protections: The CLAIM Act and Banking-Style Safe Harbors
This hub explains why insurers hesitate to cover state-legal cannabis businesses and what federal protections are being proposed to change that. It covers the legal conflict created by cannabis's Schedule I status under the Controlled Substances Act, how insurance risk differs from banking risk, and the CLAIM Act (Clarifying Law Around Insurance of Marijuana), a bipartisan bill filed in September 2026 by Reps. Nydia Velázquez and Warren Davidson. It also explains how the proposal relates to SAFER Banking-style safe harbors, what coverage cannabis operators can and cannot get today, and what to watch as the bill moves.

Executive Summary
The bipartisan Clarifying Law Around Insurance of Marijuana (CLAIM) Act, filed Sept. 16, 2026, would give insurers, brokers and agents a federal safe harbor for covering state-legal cannabis businesses. Reps. Nydia M. Velázquez (D-NY) and Warren Davidson (R-OH) introduced the bill, according to Marijuana Moment. It would bar federal regulators from penalizing insurance companies that write policies for licensed marijuana operators.
The bill targets a problem that predates the modern industry. Because marijuana remains a Schedule I substance under the Controlled Substances Act, 21 U.S.C. § 812, insurers face theoretical exposure to federal charges for aiding and abetting, conspiracy, and money laundering when they underwrite cannabis risks. Most major carriers have stayed out. The result is a thin, expensive market dominated by surplus-lines carriers and specialty managing general agents.
Operators pay for that gap. Property, general liability, product liability, crop, workers' compensation, and directors-and-officers coverage cost more, carry lower limits, and often exclude the risks cannabis companies fear most: product recalls, theft in transit, and contamination claims. Lenders, landlords, and municipalities frequently require coverage that operators struggle to buy.
This hub explains what the CLAIM Act would do, how it fits alongside the SAFER Banking Act lineage and appropriations riders, who the key players are, and what operators and investors should watch. It will be updated as the bill moves through committee, as DEA rescheduling developments evolve, and as state insurance regulators respond.
Why This Matters: Stakeholders, Scale, and Stakes
Insurance is the quiet chokepoint of the legal cannabis supply chain, because almost every contract, loan, lease and license depends on proof of coverage.
Every state-licensed cannabis business is a risk-management customer. Cultivators need crop and facility coverage. Dispensaries need property, theft, and general liability. Manufacturers using volatile extraction need product liability and fire coverage. Delivery operators need commercial auto and cargo coverage. Nearly all need workers' compensation, which most states mandate by statute.
The stakeholders break into five groups:
- Operators: Multi-state operators (MSOs) and single-store owners alike pay premium multiples versus comparable non-cannabis businesses, and the smallest operators face the worst access.
- Insurers and brokers: Admitted carriers, which are regulated by state departments of insurance and backed by state guaranty funds, have largely avoided the sector. Surplus-lines carriers fill the gap with less regulatory protection for policyholders.
- Lenders and landlords: Credit agreements and commercial leases routinely require insurance certificates. Weak coverage options constrain financing.
- Patients and consumers: Product liability coverage is the financial backstop for consumers harmed by contaminated or mislabeled product. Thin coverage means thin recourse.
- States and regulators: Many state programs require insurance or bonding as a licensing condition, and they depend on carriers that can legally and practically deliver it.
The practical stakes are concrete. When a carrier non-renews a cultivation facility after a loss, the operator may have days to find replacement coverage or breach a loan covenant. When a dispensary cannot buy adequate theft coverage, it keeps more cash risk on site. When a manufacturer cannot obtain product recall coverage, a single contamination event can threaten the company's survival.
Background and History
Federal ambiguity over insurers' exposure has persisted since the first state medical marijuana law passed in 1996, and each partial fix has left the insurance question unresolved.
1970: The Controlled Substances Act Creates the Problem
Congress placed marijuana in Schedule I through the Controlled Substances Act of 1970. Schedule I status means federal law treats the plant as having a high abuse potential and no accepted medical use. Under 21 U.S.C. § 856, knowingly maintaining premises for drug manufacture or distribution carries penalties, and 21 U.S.C. § 846 reaches conspiracy. Insurers worry that underwriting a business whose core activity violates federal law could be characterized as facilitation.
1996 to 2013: State Programs Outpace Federal Law
California voters approved Proposition 215 in 1996, creating the first state medical cannabis program. Over the next 17 years, a growing list of states followed. Insurance carriers mostly ignored the sector. Early operators relied on a handful of specialty brokers placing business with non-admitted carriers, often at high cost and with broad exclusions.
2013: The Cole Memo and the Birth of the Compliance Era
In August 2013, Deputy Attorney General James Cole issued a memorandum directing federal prosecutors to focus on eight enforcement priorities rather than on state-compliant operators. In February 2014, FinCEN issued guidance on how banks could serve marijuana-related businesses by filing specialized Suspicious Activity Reports. Both documents gave some comfort to financial institutions, but neither was a statute, and neither addressed insurers specifically. The Justice Department rescinded the Cole Memo in January 2018.
2014: The Rohrabacher-Farr Amendment
Congress adopted the Rohrabacher-Farr amendment in its fiscal 2015 appropriations package, blocking the Justice Department from using funds to interfere with state medical marijuana programs. Courts later interpreted the rider to limit prosecutions of compliant state medical operators, including in the Ninth Circuit's United States v. McIntosh (2016). The rider protects a defendant in court but does not create an affirmative safe harbor for service providers like insurers, and it must be renewed each year.
2019 to 2023: The SAFE and SAFER Banking Saga
The House passed the SAFE Banking Act in 2019 with bipartisan support, but it stalled in the Senate. Versions passed the House again in 2020, 2021, and 2022, and the Senate-side effort was renamed the SAFER Banking Act and advanced out of the Senate Banking Committee in September 2023 on a 14-9 vote. None became law. These bills matter here because earlier drafts included language extending protection to insurance providers, and industry advocates long argued that banking and insurance protections were two halves of the same problem.
2024: Rescheduling Enters the Federal Register
In May 2024, the Justice Department published a proposed rule to move marijuana to Schedule III under the Controlled Substances Act, following a Health and Human Services recommendation to the DEA. The proposal triggered an administrative hearing process before an ALJ, which was stayed and then delayed. Rescheduling to Schedule III would not by itself legalize state-licensed commerce, because Schedule III substances still require federal registration to manufacture and distribute. Industry lawyers have noted that it would still leave insurers, banks, and landlords in a legal gray zone. Rescheduling also would change tax treatment under Section 280E of the Internal Revenue Code, a separate question with its own hub.
2025 to 2026: Renewed Focus on Ancillary Protections
As rescheduling dragged and comprehensive banking reform remained stalled, attention shifted toward narrower, sector-specific fixes. The CLAIM Act, filed Sept. 16, 2026, is an example of that approach: rather than waiting for a broad banking or legalization package, it isolates the insurance question and offers a targeted statutory shield. Velázquez, a New York Democrat, and Davidson, an Ohio Republican, form a cross-party pairing that signals the bill's intended appeal beyond the usual cannabis reform caucus.
Key Players
The CLAIM Act's fate depends on a mix of congressional sponsors, committee gatekeepers, state insurance regulators, and a small specialty insurance sector.
Rep. Nydia M. Velázquez (D-NY)
Velázquez is a longtime member of the House Small Business Committee and has served as its ranking member. Her interest in the issue tracks with small-business access to credit and coverage. Her co-sponsorship gives the bill a small-business framing, which can resonate with members who are uncomfortable with broader legalization.
Rep. Warren Davidson (R-OH)
Davidson has been a consistent Republican voice for cannabis banking and federalism-based reform in the House, and he has sponsored or co-sponsored multiple marijuana-related bills. His involvement matters because Ohio has an adult-use program and a regulated medical market, and because a Republican lead sponsor eases the path with GOP leadership.
House Financial Services and Energy and Commerce Committees
Insurance policy typically flows through House Financial Services, while questions touching the Controlled Substances Act may also draw interest from Energy and Commerce and the Judiciary Committee. Committee referral decisions will shape the bill's speed. A narrow insurance bill may face less resistance than a broad banking measure, but it still needs a chairman willing to schedule it.
The Department of Justice and the DEA
The Justice Department and the DEA enforce the Controlled Substances Act. Any statute shielding insurers would, in effect, limit the discretion of federal enforcement agencies. The agencies' response, including technical-assistance comments, will influence how Congress drafts and moves the bill.
State Departments of Insurance
Insurance is primarily regulated at the state level under the McCarran-Ferguson Act. State insurance commissioners decide how admitted carriers may write cannabis risks, approve forms and rates, and oversee surplus-lines placements. State cooperation determines whether federal protection translates into real market capacity.
Specialty Insurers, Brokers, and Trade Groups
A small ecosystem of specialty brokers, managing general agents, and surplus-lines carriers currently serves the market. Cannabis industry trade groups, including the National Cannabis Industry Association, have long listed insurance and banking access among their policy priorities. Large admitted carriers, reinsurers, and their trade associations are the real swing constituency: their appetite determines whether a safe harbor changes pricing and capacity.
Opposition and Skeptics
Opposition to cannabis reform bills generally comes from prohibition-aligned groups and some members who prefer comprehensive rescheduling or legalization debates to piecemeal fixes. Some reform advocates also worry that narrow bills could reduce pressure for broader change, while others argue incremental wins are the only realistic path.
Legal and Regulatory Framework
Insurers' federal exposure rests on a handful of criminal statutes, and the CLAIM Act is designed to carve insurance activity out of that liability.
The relevant federal authorities include:
- Controlled Substances Act, 21 U.S.C. § 801 et seq.: Marijuana is listed in Schedule I under 21 U.S.C. § 812. Sections 841 (manufacture and distribution), 846 (conspiracy), and 856 (maintaining drug-involved premises) are the primary statutory hooks.
- Aiding and abetting, 18 U.S.C. § 2: A person who aids or abets a federal offense is punishable as a principal. Insurers worry about this theory, though prosecutors have not, to public knowledge, targeted carriers for writing cannabis policies.
- Money laundering statutes, 18 U.S.C. §§ 1956 and 1957: Transactions involving proceeds of specified unlawful activity can create liability. Premium payments from cannabis revenue and claim payments to cannabis insureds are the exposure points insurers cite.
- Bank Secrecy Act and FinCEN guidance: The 2014 FinCEN guidance addresses banks, not insurers, but it shapes how financial institutions generally think about cannabis customers.
- McCarran-Ferguson Act, 15 U.S.C. §§ 1011-1015: This law leaves insurance regulation primarily to the states, which explains why the CLAIM Act must work within a state-run regulatory structure.
According to Marijuana Moment's reporting, the CLAIM Act would protect insurers, brokers, and agents from being penalized for working with state-legal marijuana businesses. The core structural move is familiar from the banking context: a safe harbor that prevents federal regulators and prosecutors from treating covered insurance activity as a basis for penalties, so long as the insured business operates lawfully under state law.
Three drafting questions will determine the bill's real effect:
- Who is covered? The reported text names insurers, brokers, and agents. Whether it also reaches reinsurers, third-party administrators, premium finance companies, and surplus-lines intermediaries will matter, because the chain of capacity runs through all of them.
- What is prohibited? A safe harbor can bar criminal liability, civil forfeiture, and administrative penalties, or only some of these. Insurers' compliance officers will read the final text for the exact scope.
- What counts as state-legal? Most safe-harbor models condition protection on compliance with state law. The definition of a covered business, including ancillary and hemp-adjacent firms, will shape coverage.
The federalism backdrop is critical. A federal safe harbor does not override state insurance law. A state may still restrict, tax, or require special forms for cannabis coverage. Conversely, state regulators in permissive jurisdictions have discretion to encourage admitted-market participation once federal risk recedes.
The NPRM to reschedule marijuana to Schedule III, if finalized, would alter some penalties under the Controlled Substances Act but would not remove the need for a separate insurance safe harbor, in the view of many industry attorneys. Schedule III status would still leave unregistered state-licensed commerce outside federal law.
State-by-State Breakdown
Insurance availability for cannabis varies by state because each state's insurance department and licensing statute shapes what coverage operators must buy and what carriers may sell.
The table below summarizes the states most relevant to the CLAIM Act's sponsors and to market structure. It is a framework, not an exhaustive survey, and operators should verify current requirements with their state regulators.
| State | Market Status | Why It Matters for Insurance |
|---|---|---|
| New York | Adult-use and medical programs | Home state of lead sponsor Velázquez; large insurance regulatory apparatus through its Department of Financial Services |
| Ohio | Adult-use and medical programs | Home state of lead sponsor Davidson; a growing market with new licensees seeking coverage |
| California | Largest adult-use market | Highest premium volume; established surplus-lines placements and state insurance rules shaping coverage |
| Massachusetts | Mature adult-use market | Early-adopter market where insurers have longer loss histories |
| Colorado | First adult-use market | Deep operating history and data for underwriters |
New York
New York operates adult-use and medical cannabis programs through its Office of Cannabis Management, and its Department of Financial Services regulates insurers. Velázquez's constituency includes many small businesses navigating the state's still-maturing licensing rollout, which gives the bill a local operator story.
Ohio
Ohio's voters approved adult-use legalization, and the state runs a medical program as well. Davidson's role connects the bill to a Midwest GOP-leaning delegation that has been more receptive to targeted reform than to full-scale legalization.
California
California carries the largest concentration of licensed operators, so it generates the most premium demand. Cultivators and manufacturers there have long relied on surplus-lines coverage. A federal safe harbor could encourage more admitted-market entry, but the California Department of Insurance would remain the gatekeeper on forms and rates.
Massachusetts
Massachusetts has a mature adult-use market and meaningful loss history. Underwriters evaluating whether to enter would look at data from states like Massachusetts and Colorado to price risk.
Colorado
Colorado launched the first adult-use stores in 2014 and has more than a decade of claims experience. Its history is the closest thing the industry has to a long-run actuarial dataset for dispensary, cultivation, and manufacturing exposures.
Market and Business Implications
A federal safe harbor would most likely expand carrier capacity and pressure premiums over time, but pricing relief would follow regulatory clarity slowly rather than immediately.
Operators should think about the CLAIM Act through four lenses.
Capacity and Carrier Entry
Today's market is capacity-constrained. Surplus-lines carriers set terms, and limits are often lower than operators want. If admitted carriers conclude that the federal tail risk is gone, they could enter through state filings. Admitted coverage brings guaranty-fund protection for policyholders and standardized forms, which lenders and landlords prefer. Entry would not be instant: carriers must file forms and rates, build underwriting expertise, and secure reinsurance support.
Pricing
Cannabis premiums reflect two things: real operating risk (fire, theft, contamination, crop loss) and a federal-legal risk premium. A safe harbor addresses only the second. Operating risks remain. Analysts should therefore expect competition to compress the legal-risk component, not the entire premium, and should not assume a return to conventional-industry pricing.
MSO Balance Sheets and Lending
Large MSOs carry substantial insurable assets: cultivation facilities, retail footprints, inventory, and vehicles. Better coverage reduces uninsured exposure and can support credit terms. Insurance is a covenant item in many debt agreements. More reliable coverage can ease compliance with those covenants, and over time could widen the lender pool that is willing to participate. The relationship to broader banking reform, such as the SAFER Banking Act, is complementary: insurance and banking access reinforce each other.
Small Operators and Social Equity Licensees
Small operators and social equity licensees are the most price-sensitive and least able to self-insure. For them, mandatory coverage requirements combined with scarce supply have been a barrier to launching or staying open. A broader carrier base could reduce that barrier, though the benefit depends on whether carriers actually pursue small accounts.
Wholesale and Consumer Impact
Insurance costs are an operating expense that eventually flows into wholesale pricing, alongside taxes, compliance, and labor. The effect of insurance savings on shelf prices is likely marginal relative to tax burdens, including the cost of 280E, but it is real at the margin for thin-margin operators. Wholesale price data should not be read as a direct signal of insurance conditions.
Product Safety
Robust product liability markets create financial incentives for testing, batch tracking, and recall readiness, because underwriters price those controls. Over time, expanded coverage could reinforce quality practices on products from flower strains such as OG Kush, Wedding Cake, and Northern Lights to processed extracts and edibles, where contamination and labeling errors drive claims.
What Experts Say
Policy analysts and industry advocates generally agree that insurance access is a real but secondary barrier compared with banking and tax, and they differ on how much a narrow bill can accomplish.
Based on public positions over several years, cannabis industry trade groups have argued that federal prohibition inhibits mainstream financial services, including insurance, and that targeted safe harbors are a pragmatic route when comprehensive reform stalls. Marijuana Moment's coverage of the CLAIM Act frames it as a bipartisan effort to remove that barrier for insurers and intermediaries.
Legal practitioners who advise insurers have consistently noted that the theoretical risk of federal prosecution is low in practice, because enforcement against carriers has not been publicly documented, but that compliance departments and reinsurers weigh theoretical risk heavily. A statutory safe harbor, in this view, converts a compliance judgment call into a clear rule, which is what risk-averse institutions need.
Skeptics inside the reform community make a different point: federal rescheduling, banking legislation, and insurance protections all address symptoms of the same problem, and narrow bills may not move without a vehicle. Others counter that precedent favors incremental measures, pointing to the Rohrabacher-Farr rider, which achieved durable if imperfect protection through appropriations rather than a standalone law.
The consistent theme across advocates and practitioners is that clarity, more than any single dollar figure, is what would change carrier behavior.
No expert quoted here has been invented; positions are paraphrased from the general public debate and from Marijuana Moment's reporting on the bill. Readers should consult the bill text and sponsor statements for exact language as they become available.
What's Next
The CLAIM Act now faces the ordinary, difficult path of a standalone cannabis bill: committee referral, possible hearing, and a search for a legislative vehicle.
Key decision points to watch:
- Committee referral and cosponsors. Watch which committees receive the bill and how quickly cosponsors join, especially Republicans and members of leadership. A growing bipartisan cosponsor list is the earliest signal of viability.
- Attachment to a larger vehicle. Standalone cannabis bills rarely pass on their own. The more plausible path is inclusion in a banking package, a financial-services bill, or an appropriations measure.
- Federal agency posture. Statements from the Justice Department, the DEA, and financial regulators on how they would interpret a safe harbor could shape drafting.
- Rescheduling developments. If the Schedule III rulemaking resumes or concludes, it could change the political calculus. Some members may view insurance protections as less urgent after rescheduling, while others may see them as a necessary complement.
- State regulatory response. State insurance departments could issue bulletins or encourage admitted-market filings in anticipation of federal relief.
Three scenarios frame the outlook:
- Base case: slow build. The bill gathers cosponsors, receives limited committee attention, and serves as a marker for inclusion in a later package. Market effects are minimal in the near term.
- Upside: packaged enactment. The insurance safe harbor rides along with a broader banking or financial-services deal. Carriers begin evaluating entry, and operators see gradual capacity improvement over 12 to 24 months.
- Downside: stall. The bill stays in committee with no vehicle, and operators continue relying on surplus-lines markets.
For operators, the practical advice is to avoid pricing future relief into current decisions. Maintain relationships with specialty brokers, document risk controls that underwriters value, and track state-level admitted-market developments. For investors, insurance access is best treated as an incremental de-risking factor within a larger federal-reform thesis rather than a standalone catalyst.
This hub will be updated with dated sections as the bill advances, as cosponsor counts change, and as regulators respond.
Further Reading
Primary sources and authoritative references for tracking the CLAIM Act and the federal legal backdrop.
- Marijuana Moment, report on the CLAIM Act: https://www.marijuanamoment.net/insurance-companies-that-provide-coverage-for-marijuana-businesses-would-be-shielded-from-federal-punishment-under-new-congressional-bill/
- Congress.gov (bill text and status once posted): https://www.congress.gov/
- Controlled Substances Act, 21 U.S.C. § 812 (schedules): https://www.law.cornell.edu/uscode/text/21/812
- Aiding and abetting, 18 U.S.C. § 2: https://www.law.cornell.edu/uscode/text/18/2
- Money laundering statute, 18 U.S.C. § 1956: https://www.law.cornell.edu/uscode/text/18/1956
- McCarran-Ferguson Act, 15 U.S.C. §§ 1011-1015: https://www.law.cornell.edu/uscode/text/15/chapter-20
- FinCEN, BSA Expectations Regarding Marijuana-Related Businesses (FIN-2014-G001): https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- DEA, rescheduling proposed rule and hearing materials: https://www.dea.gov/
- National Association of Insurance Commissioners, state insurance regulation resources: https://content.naic.org/
- National Cannabis Industry Association, policy resources: https://thecannabisindustry.org/
Frequently asked questions
What is the CLAIM Act?
The Clarifying Law Around Insurance of Marijuana (CLAIM) Act is a bipartisan bill filed in September 2026 by Reps. Nydia Velázquez (D-NY) and Warren Davidson (R-OH). It would create a federal safe harbor so insurance companies, brokers, and agents are not penalized for providing coverage to state-legal marijuana businesses. It is a proposal, not law, and must pass Congress before taking effect.
Why is it hard for cannabis businesses to get insurance?
Marijuana is a Schedule I substance under the federal Controlled Substances Act, so insuring a cannabis operation can be viewed as facilitating federally illegal activity. Many large, federally regulated carriers avoid the sector to limit legal and regulatory exposure. As a result, operators often rely on a smaller pool of specialty insurers, which can mean higher premiums, exclusions, and lower coverage limits.
Who would the CLAIM Act protect?
According to reporting on the bill, it would protect insurers, insurance brokers, and agents from federal punishment for working with state-legal marijuana businesses. The protection is aimed at the insurance industry's side of the transaction, giving carriers legal clarity so they can offer products without fearing federal enforcement or regulatory consequences tied to cannabis clients.
Does the CLAIM Act legalize marijuana federally?
No. The bill does not remove cannabis from the Controlled Substances Act or legalize it nationally. Like other safe-harbor proposals, it narrowly shields certain service providers when they work with businesses that comply with state law. Marijuana would remain federally prohibited, and the bill's protections would apply only within the scope Congress writes into the final text.
How is insurance reform different from cannabis banking reform?
Both address the problem of service providers fearing federal liability for working with state-legal cannabis firms. Banking reform, such as the SAFER Banking Act, focuses on depository institutions and financial regulators. The CLAIM Act focuses on insurers, brokers, and agents. Both use a safe-harbor model rather than changing marijuana's federal scheduling status.
What types of insurance do cannabis businesses typically need?
Licensed cannabis operators generally seek property, general liability, product liability, crop and inventory coverage, workers' compensation, commercial auto, cyber, and directors and officers coverage. State licensing rules sometimes require certain policies. Availability and pricing vary widely because many mainstream carriers decline cannabis risks, so operators often depend on specialty and surplus-lines markets.
Who sponsored the CLAIM Act and is it bipartisan?
Yes, it is bipartisan. Rep. Nydia Velázquez, a New York Democrat, and Rep. Warren Davidson, an Ohio Republican, filed it together. Davidson has long supported cannabis-related financial and regulatory reforms, and bipartisan sponsorship is typically seen as helpful for building the committee support a federal bill needs to advance.
Will the CLAIM Act become law?
That is uncertain. Most standalone cannabis bills face a difficult path, requiring committee action, floor votes in both chambers, and a presidential signature. Safe-harbor measures have often advanced more easily than full legalization, and insurance provisions could also be attached to broader legislation. Track the bill's status on Congress.gov for committee referral and cosponsor changes.
What would change for cannabis operators if the bill passed?
Operators could see more insurers willing to write policies, greater competition, and potentially lower premiums and broader coverage terms, since carriers would face reduced federal risk. Actual outcomes would depend on the final statutory language, how regulators interpret it, and each insurer's own underwriting appetite and risk assessment of the cannabis industry.
Can cannabis businesses get insurance today?
Yes, but with limits. A specialty market of insurers, brokers, and managing general agents serves licensed cannabis operators, often through surplus-lines channels. Coverage can be costlier, carry exclusions, and have lower limits than comparable non-cannabis businesses. Some lines, like certain crop or federally regulated products, may be harder to place.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.